相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases
Fernando Pereira et al.
BMC CANCER (2022)
Colorectal cancer cells from patients treated with FOLFOX or CAPOX are resistant to oxaliplatin
Robert A. Nagourney et al.
EJSO (2021)
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial
Francois Quenet et al.
LANCET ONCOLOGY (2021)
Randomized controlled trials in surgical resection of colorectal peritoneal metastases: Disentangling negativity in PRODIGE 7 and PROPHYLOCHIP
Brendan J. Moran et al.
COLORECTAL DISEASE (2021)
Limitations of the PRODIGE 7 trial
Michael A Ströhlein et al.
LANCET ONCOLOGY (2021)
Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases A Phase 2 Randomized Clinical Trial
Koen P. Rovers et al.
JAMA SURGERY (2021)
Hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases: lessons learned from PRODIGE 7
Peter Cashin et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2021)
Effect of oxaliplatin-based chemotherapy on chemosensitivity in patients with peritoneal metastasis from colorectal cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: proof-of-concept study
A. Prabhu et al.
BJS OPEN (2021)
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Colorectal Metastases
ANNALS OF SURGICAL ONCOLOGY (2020)
Prognostic Utility of Pre- and Postoperative Circulating Tumor DNA Liquid Biopsies in Patients with Peritoneal Metastases
Joel M. Baumgartner et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Circulating Tumor DNA as a Preoperative Marker of Recurrence in Patients with Peritoneal Metastases of Colorectal Cancer: A Clinical Feasibility Study
Jamie J. Beagan et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study
Diane Goere et al.
LANCET ONCOLOGY (2020)
Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parralel-group, phase II-III, randomised, superiority study (CAIRO6)
Koen P. Rovers et al.
BMC CANCER (2019)
Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial
Charlotte E. L. Klaver et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
Techniques for Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy
Rebecca M. Dodson et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Patterns of metastasis in colon and rectal cancer
Matias Riihimaki et al.
SCIENTIFIC REPORTS (2016)
Epidemiology, Management, and Survival of Peritoneal Carcinomatosis from Colorectal Cancer: A Population-Based Study
P. Quere et al.
DISEASES OF THE COLON & RECTUM (2015)
The use of Oxaliplatin or Mitomycin C in HIPEC treatment for peritoneal carcinomatosis from colorectal cancer: A comparative study
D. Hompes et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)
Incidence, Prognosis, and Treatment Options for Patients With Synchronous Peritoneal Carcinomatosis and Liver Metastases from Colorectal Origin
Irene Thomassen et al.
DISEASES OF THE COLON & RECTUM (2013)
Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer
J. Segelman et al.
BRITISH JOURNAL OF SURGERY (2012)
8-year follow-up of randomized trial: Cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer
Vic J. Verwaal et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Exposure-response relationships for oxaliplatin-treated colon cancer cells
Mark N. Kirstein et al.
ANTI-CANCER DRUGS (2008)
Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy
P. H. Sugarbaker
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2007)
Peritoneal carcinomatosis of colorectal origin - Incidence and current treatment strategies
MJ Koppe et al.
ANNALS OF SURGERY (2006)
Peritoneal carcinomatosis from colorectal or appendiceal origin:: Correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement
E De Bree et al.
JOURNAL OF SURGICAL ONCOLOGY (2004)
Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer
VJ Verwaal et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
分享论文
